The symptoms asymmetry of drug-induced parkinsonism is not related to nigrostriatal cell degeneration: a SPECT-DaTSCAN study

Neurol Neurochir Pol. 2019;53(4):311-314. doi: 10.5603/PJNNS.a2019.0031. Epub 2019 Aug 23.

Abstract

Aim: Drug-induced parkinsonism (DIP) is the most common form of parkinsonism after Parkinson's disease (PD) itself. It has been widely believed that DIP is characterised by symmetry of symptoms. Studies of patients with DIP in whom PD had been ruled out by SPECT-DaTSCAN have shown that symptom asymmetry is a common element of DIP clinical presentation. The aim of our study was to determine whether the asymmetry of symptoms in DIP is related to any abnormality within the presynaptic part of the nigrostriatal dopaminergic system.

Materials and methods: Eleven patients with the diagnosis of DIP and asymmetric symptoms were studied. Their individual SPECT-DaTSCANs were normal. Indices calculated for the whole group of radiotracer uptake in the whole striatum, putamen and caudate contralateral to more severe DIP symptoms were compared to values obtained in the opposite hemisphere.

Results: We did not find significant differences in radiotracer uptake in structures contralateral to more severe clinical symptoms when compared to the homolateral hemisphere.

Conclusions: Our results have not confirmed the presence of a presynaptic nigrostriatal deficit which could be related to asymmetry of DIP. The factors responsible for the asymmetry of DIP symptoms should be sought in the postsynaptic part of the nigrostriatal dopaminergic system.

Keywords: SPECT-DaTSCAN; asymmetry of symptoms; drug-induced parkinsonism; presynaptic nigrostriatal deficit.

MeSH terms

  • Dopamine Plasma Membrane Transport Proteins
  • Humans
  • Parkinsonian Disorders* / diagnostic imaging
  • Tomography, Emission-Computed, Single-Photon
  • Tropanes

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Tropanes